|
|
Á¦¸ñ |
|
Á¦5ȸ Çѱ¹ºÎÀξÏÀç´Ü ½ÉÆ÷Áö¿ò-The 1st Seoul International Sy |
|
|
|
³¯Â¥ |
|
2005-08-17 |
|
|
Á¶È¸¼ö |
|
3979 |
|
|
ÆÄÀÏ |
|
[ÈÀϾøÀ½] |
|
|
The 1st
International Symposium on Papillomavirus - Recent Trends in Research, Development, Clinical Practice and Evaluation Technology - (The 5th Annual Symposium of Korean Gynecologic Cancer Foundation)
| Jointly Organized by Korean Gynecologic Cancer Foundation/Korea Food & Drug AdministrationSeoul, Korea, 4 - 5 September, 2005 Agenda Moderator : Dr. Sue Nie Park (KFDA) Sep. 04, 2005 (Sunday) | | Auditorium at Clinical Research Institute (Seoul National Univ. Hospital) | | 08:30 - 09:00 | Registration Prof. Jae Weon Kim (KGCF) & Ms. Soon Nam Kim (KFDA) | 09:00 - 09:10 | Opening Address Prof. Hyo Pyo Lee (President, KGCF) | 09:10 - 09:20 | Welcoming Remarks Dr. Chung Sook Kim (Commissioner, KFDA | 09:20 - 09:30 | Congratulatory Remarks I Prof. Sung Ro Chung (Chief Director, KSOG) | 09:30 - 09:40 | Congratulatory Remarks II Prof.. Gil-Ja Jhon (Director General, NIS-WIST) |
| | PLENARY SESSION: Recent Progress in Researches on Papillomavirus Infection Chair: Prof. Jae-Wook Kim (Yonsei Univ. College of Medicine)Prof. Kuy Wan Lee (Korea Univ.) | |
09:40 - 10:20 | Plenary Talk (I) Papillomavirus and Diseases Dr. John T. Schiller (NCI, NIH, USA) | 10:20 - 11:00 | Plenary Talk (II) The Role of HPV Variants and Hereditary Factors in Cervical Cancer Prof. Yong Sang Song (Seoul National Univ.) | 11:00 - 11:10 | Coffee break |
| |
SESSION I. Current Status
of Papillomavirus Drug Development Chair: Dr. Won Shin (KFDA) Prof. Kyung Tai 11:10 - 11:40 |
Papillomavirus and Therapeutics including Therapeutic Vaccine Dr. Thomas Jonathan Chambers (MSD, USA) |
11:40 - 12:10 | HPV Vaccine Research in Korea
Dr. Haryoung Poo (KRIBB) | 12:10 - 12:40 | Considerations and Validation of HCII HPV DNA for Cervical Cancer Screening. Mr. Mark Van Asten (Digene Inc., Australia) | 12:40 - 14:00 | Lunch |
|
| SESSION II. International Practice Trends on Clinical Utility of HPV DNA Test in Clinical Management Chair: Dr. Yeowon Sohn (KFDA) Prof. Joo-Hyun Nam (Ulsan Univ.) | | 14:00 - 14:30 | Australian Case Study Prof. Suzanne Garland (Royal Women’s Hospital, Australia) | 14:30 - 15:00 | China Case Study Prof. You-Lin Qiao (Peking Union Medical College, China) | 15:00 - 15:30 | Korean Case Study Prof. Jong Sup Park (Catholic Univ.) | 15:30 - 15:50 | Coffee break |
| | SESSION III. Innovative Strategy of National Regulatory Authorities Chair: Dr. Sook Jin Hur (KFDA) Prof. Ho Suk Suh (Korea Univ.) | |
15:50 - 16:20 | Accreditation of WHO Global Laboratory Network and WHO International Reference Reagents Dr. Sue Nie Park (KFDA) | 16:20 - 16:50 | Establishment of Korean National References Prof. Joo Sung Yang (SungKyunGwan Univ..) | 16:50 - 17:20 | Establishment of Neutralizing Antibody Assay Methodology for Standardizing Efficacy Tests and Current Status of Establishing HPV VLP References Prof. Hong Jin Kim (ChoongAng Univ..) | | |
Concluding Remarks |
| 17:20 - 17:30 | Remarks by Director General, DBE
Dr. Hong Ki Min (KFDA) | 18:00 - 21:00 | Reception |
| |
Sep.. 5, 2005 (Monday) Satellite Meeting to the 1st International Symposium on PapillomavirusInternational Meeting Room (DBE Building, KFDA) | |
Program | | 09:30 - 09:40 | Opening Remarks Dr. Hong Ki Min (KFDA) |
| | SESSION (9:40 – 12:00) Vision on Papillomavirus Drug Production and Development: Chance and Risk for Vaccine and Other Drugs Chair : Dr. Seung Hwa Hong (KFDA) | | 09:40-10:10 | Dr. John T. Schiller (NCI, NIH, USA) |
10:10-10:40 | Dr. Thomas Jonathan Chambers (MSD, USA) |
| | Panelists : Dr. Chung Keel Lee (KFDA) Dr. Suzanne Garland (Royal Women’s Hospital, Australia) Dr. You-Lin Qiao (Peking Union Medical College, China) Dr. Jeong Jin Lee (LG-Life Sciences, Ltd.) | | | | | | Âü°¡ µî·Ï½Åû¼ ´Ù¿î·Îµå | |
|
|
|
|
|
|
|